Sign Up Today and Learn More About Olive Stock
Invest in or calculate the value of your shares in Olive or other pre-IPO companies through EquityZen's platform.
About Olive Stock
Founded
2012
Headquarters
Columbus, OH, US
Total Funding
35.0M
Industries
Software, Artificial Intelligence, Data and Analytics
Olive deploys the AI workforce built specifically for healthcare, delivering hospitals and health systems increased revenue, reduced costs, and increased capacity. Olive automates repetitive, high-volume tasks and workflows, monitoring their performance, identifying improvements, and finding opportunities for new work. Olive gives power back to providers through her ever-growing, unparalleled intelligence made up of shared memories, collective wisdom, and global awareness, learning like a network so hospitals never have to solve the same problem twice. Olive was founded in 2012 and is headquartered in Columbus, Ohio.
Olive Press Mentions
Stay in the know about the latest news on Olive
Global Venture Funding In October Dips Below 2023 Average
news • Nov 06, 2023
Olive AI has been sold for parts. Here's what we know about the buyers.
bizjournals • Nov 04, 2023
The Crunchbase Tech Layoffs Tracker
news • Nov 03, 2023
Columbus startup Olive shuts down after raising over $850 million
coverager • Nov 01, 2023
Once a high-flying 'unicorn,' Olive AI sells two key businesses, winds down operations
fiercehealthcare • Nov 01, 2023
Investors in Olive
Discover investors in Olive stock and explore their portfolio companies
Olive Management
Leadership team at Olive
Chief Executive Officer
Sean Lane
Chief Financial Officer
Ali Byrd
Join now and verify your accreditation status to gain access to:
- Olive Current Valuation
- Olive Stock Price
- Olive Management
- Available deals in Olive and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Olive Cap Table and Funding History by Share Class and Liquidity Preferences
- Olive Revenue and Financials
- Olive Highlights
- Olive Business Model
- Olive Risk Factors
- Olive Research Report from SACRA Research
Trading Olive Stock
How to invest in Olive stock?
Accredited investors can buy pre-IPO stock in companies like Olive through EquityZen funds. These investments are made available by existing Olive shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Olive stock?
Shareholders can sell their Olive stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."